Bittium (BITTI) Company presentation summary

Company overview and market position

• Operates globally in high-technology sectors with a focus on secure, sustainable, and health-oriented solutions.

• Headquarters in Oulu, Finland, with ~575 employees and offices in Finland, UK, Germany, and USA.

• Listed on Nasdaq Helsinki, with net sales of €119.3M and an operating result of €19.4M in 2025.

• Business segments: Defence & Security (72% of 2025 net sales), Medical (16%), Engineering Services (12%).

Defence & security segment

• Key supplier for Finnish Defence Forces and partner to multiple European armed forces.

• Offers resilient, secure tactical communications across land, sea, air, and unmanned domains.

• Products include next-gen tactical radios, secure mobile communications, and software routers.

• Significant international partnerships and licensing agreements, including with Lockheed Martin, BAE Systems, and Indra Group.

• Defence & Security net sales grew 65.8% to €85.5M in 2025, with a 24.8% EBIT margin.

Medical segment

• Focuses on remote monitoring and diagnostics, especially ECG and sleep apnea markets.

• Remote ECG market valued at $5–9B with 7–10% CAGR; exclusive contract with a leading cardiac company.

• Home sleep apnea test (HSAT) market valued at $2.9B with 10–17% CAGR; high prevalence and underdiagnosis drive growth.

• Medical net sales reached €10.1M in 1H 2026, with a 6.3% growth rate and €0.6M EBIT.